Xiaojuan Zheng

Title: Innovations of Inventor Xiaojuan Zheng

Introduction

Xiaojuan Zheng is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and monoclonal antibodies. With a total of 2 patents, his work has the potential to impact animal health and disease prevention.

Latest Patents

Xiaojuan Zheng's latest patents include the following:

1. **Hybridoma Cell Line for Secreting Anti-Rabies Virus M Protein Monoclonal Antibody and Application Thereof**.

2. **Type II Pseudorabies Virus Attenuated Strain, Its Preparation Method and Application**. This invention discloses a type II Pseudorabies virus attenuated strain and its preparation method and application. The attenuated strain of pseudorabies virus is a gE/TK-double-deficient strain, named PRV-HD/c strain of PRV dual-deletion strain, with the accession number CGMCC No. 14325. This strain is derived from a newly isolated strain of pseudorabies virus type II after the deletion of the gE and TK double genes. It exhibits reduced pathogenicity and strong immunogenicity, providing effective immunity to PRV susceptible animals such as pigs and mice.

Career Highlights

Xiaojuan Zheng is affiliated with Zhejiang University, where he conducts his research and development activities. His work is recognized for its innovative approach to addressing viral infections in animals.

Collaborations

Xiaojuan Zheng collaborates with several colleagues, including Min Liao and Yulan Jin, who contribute to his research efforts.

Conclusion

Xiaojuan Zheng's contributions to biotechnology through his patents demonstrate his commitment to advancing animal health. His innovative work in developing effective vaccines and antibodies is crucial for disease prevention in livestock.